Published in Clin Transpl on January 01, 1989
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant (1997) 0.79
Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention. Graft (Georget Tex) (1998) 0.76
THE ROUTE OF RE-CIRCULATION OF LYMPHOCYTES IN THE RAT. Proc R Soc Lond B Biol Sci (1964) 20.20
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16
Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum (1969) 2.80
Mechanism of T cell activation: role and functional relationship of HLA-DR antigens and interleukins. Immunol Rev (1982) 2.44
Isohemagglutinins of graft origin after ABO-unmatched liver transplantation. N Engl J Med (1984) 2.25
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18
SPLENIC HOMOTRANSPLANTATION. Ann N Y Acad Sci (1964) 2.01
The major histocompatibility complex--genetics and biology. (First of three parts). N Engl J Med (1976) 1.92
Prolongation of islet allograft survival following in vitro culture (24 degrees C) and a single injection of ALS. Science (1979) 1.82
Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. Hum Immunol (1985) 1.65
Why are lung allografts more vigorously rejected than hearts? J Heart Transplant (1987) 1.26
The rapid elimination of allogeneic lymphocytes: relationship to established mechanisms of immunity and to lymphocyte traffic. Immunol Rev (1983) 1.16
Tumor immunity in rat lymph nodes following transplantation. Ann Surg (1982) 1.05
Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants. Immunogenetics (1982) 1.04
Emergence of red blood cell agglutinins following renal transplantation in a patient with systemic lupus erythematosus. Transplantation (1981) 1.02
The effect of histocompatibility antigens on lymphocyte migration in the mouse. Immunology (1972) 1.02
Natural cytotoxicity: early killing of allogeneic lymphocytes in rats. Immunol Rev (1983) 0.99
Lethal graft-versus-host disease in a recipient of a pancreas-spleen transplant. Transplantation (1986) 0.99
REGENERATION AND AUTOTRANSPLANTATION OF LYMPH NODES. Ann Surg (1965) 0.96
Double immunoenzyme staining method for analysis of tissue and blood lymphocyte subsets with monoclonal antibodies. Lab Invest (1987) 0.90
Lymphocytes of bronchoalveolar lavages from heart-lung transplant recipients. J Heart Transplant (1987) 0.89
Liver rejection and its differentiation from other causes of graft dysfunction. Semin Liver Dis (1985) 0.89
Autotransplantation of lymph nodes in the dog. Surg Forum (1965) 0.85
H-2 restriction for lymphocyte homing into lymph nodes. Eur J Immunol (1979) 0.85
HLA phenotype of lung lavage cells following heart-lung transplantation. J Heart Transplant (1987) 0.83
Changes in mixed lymphocyte culture-reactive lymphocytes following alloimmunization of single lymph nodes in sheep. Transplantation (1979) 0.82
Lymphocyte migration across major histocompatibility barriers in splenectomized rats. Immunol Rev (1983) 0.81
Lymphocyte recruitment properties of regional lymph node or spleen cells during skin allograft rejection. Transplantation (1983) 0.78
Production of alpha 1,3-galactosyltransferase-deficient pigs. Science (2002) 3.96
Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nat Biotechnol (2006) 3.07
VENO-VENOUS BYPASS WITHOUT SYSTEMIC ANTICOAGULATION IN CANINE AND HUMAN LIVER TRANSPLANTATION. Surg Forum (1983) 2.30
THE USE OF COMBINED PRESERVATION TECHNIQUES FOR EXTENDED STORAGE OF ORTHOTOPIC LIVER HOMOGRAFTS. Surg Gynecol Obstet (1968) 2.20
Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology (2005) 2.02
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93
The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med (2005) 1.75
Complications of right lobe living donor liver transplantation. J Hepatol (2009) 1.73
IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J Immunol (2011) 1.72
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation (2008) 1.62
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61
Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis. Hepatology (2003) 1.61
EFFECT OF CYCLOSPORIN ON HEPATIC REGENERATION. Surg Forum (1986) 1.59
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52
The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers. Liver Transpl (2008) 1.51
Functionally important glycosyltransferase gain and loss during catarrhine primate emergence. Proc Natl Acad Sci U S A (2006) 1.46
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43
Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short. Transplantation (2007) 1.42
SUCCESSFUL ORTHOTOPIC TRANSPLANTATION OF LIVER HOMOGRAFTS AFTER EIGHT TO TWENTY-FIVE HOURS PRESERVATION. Surg Forum (1967) 1.37
Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr (2006) 1.36
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30
Porcine partial liver transplantation: a novel model of the "small-for-size" liver graft. Liver Transpl (2004) 1.22
Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest. Cancer Res (2004) 1.21
Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology (2002) 1.21
Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem (2001) 1.18
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation (2003) 1.18
85-kDa cytosolic phospholipase A2 mediates peroxisome proliferator-activated receptor gamma activation in human lung epithelial cells. J Biol Chem (2002) 1.13
Retracted Modulation of Stat3 activation by the cytosolic phospholipase A2alpha and cyclooxygenase-2-controlled prostaglandin E2 signaling pathway. J Biol Chem (2006) 1.13
OKT3 and viral disease in pediatric liver transplant recipients. Clin Transplant (1991) 1.11
Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg (2005) 1.10
Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes. J Hepatol (2008) 1.04
Differential immunogenicity of HLA mismatches in clinical transplantation. Transpl Immunol (2005) 1.03
The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant (2005) 1.02
A schema for histologic grading of small intestine allograft acute rejection. Transplantation (2003) 1.02
Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells. Hepatology (2002) 1.02
HLA matching for kidney transplantation. Hum Immunol (2004) 1.00
HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant (2004) 0.99
Humoral Antibodies in Patients After Renal Homotransplantation. Transplantation (1967) 0.96
Extending options for highly sensitized patients to receive a suitable kidney graft. Curr Opin Immunol (2005) 0.96
Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant (2005) 0.95
Human leukocyte antigen epitope analysis to assess complement- and non-complement-binding donor-specific antibody repertoire in a pediatric heart transplant recipient. Hum Immunol (2011) 0.95
Human dominant-negative class II transactivator transgenic pigs - effect on the human anti-pig T-cell immune response and immune status. Immunology (2013) 0.95
Functional characteristics of lymphocytes propagated from a human multivisceral allograft. Clin Transplant (1990) 0.94
HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients. Blood (2005) 0.93
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. Transplantation (2004) 0.91
Tacrolimus (FK506)-Associated Renal Pathology. Adv Anat Pathol (1997) 0.90
Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol (2003) 0.89
A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C. Hepatology (2002) 0.89
PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway. Hepatology (2003) 0.89
How did a patient who types for HLA-B*4403 develop antibodies that react with HLA-B*4402? Hum Immunol (2009) 0.88
Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol (2002) 0.88
Immunosuppressive therapy and tolerance of organ allografts. N Engl J Med (2008) 0.88
ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS. Clin Transplant (1988) 0.87
The treatment of penetrating wounds of the inferior vena cava. Surgery (1962) 0.86
Cholera toxin-sensitive GTP-binding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat kupffer cells. J Cell Physiol (2010) 0.85
Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Hepatology (2008) 0.84
Human monoclonal antibody reactivity with human leukocyte antigen class I epitopes defined by pairs of mismatched eplets and self-eplets. Transplantation (2010) 0.83
85-kDa cPLA(2) plays a critical role in PPAR-mediated gene transcription in human hepatoma cells. Am J Physiol Gastrointest Liver Physiol (2002) 0.83
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. Transplantation (2006) 0.82
Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant. Transpl Immunol (2009) 0.82
Smooth muscle tumor arising de novo in a liver allograft: A case report. Clin Transplant (1991) 0.82
Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism. Blood (2006) 0.82
HLAMatchmaker algorithm is not a suitable tool to predict the alloreactive cytotoxic T-lymphocyte response in vitro. Transplantation (2004) 0.82
Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: with particular emphasis on donor major histocompatibility complex class II+ cells. Transplantation (2002) 0.81
Hepatic artery thrombosis following pediatric liver transplantation: Assessment of blood flow measurement in allografts. Clin Transplant (1989) 0.81
Pancreatic transplantation at the University of Pittsburgh. Clin Transpl (2004) 0.81
Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. Clin Transplant (1992) 0.80
Brief report: Why did two patients who type for HLA-B13 have antibodies that react with all Bw4 antigens except HLA-B13? Transpl Immunol (2011) 0.80
Hepatic antigen-presenting cells and regulation of liver transplant outcome. Immunol Res (2011) 0.79
Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in Man. Transplant Sci (1993) 0.78
Cadaveric renal transplantation using kidneys from donors greater than 60 years old. Clin Transplant (1992) 0.78
Kidney after nonrenal transplantation-the impact of alemtuzumab induction. Transplantation (2009) 0.78
Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol (2002) 0.78
Tolerance for organ recipients: a clash of paradigms. Liver Transpl (2006) 0.78
Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients. Pediatr Transplant (2006) 0.78
Induction of Pancreatic Islet Graft Acceptance: The Role of Antigen Presenting Cells. Transplant Sci (1992) 0.78
Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation. Liver Transpl (2008) 0.78
Is the application of HLAMatchmaker relevant in kidney transplantation? Transplantation (2005) 0.78
Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy. Transplantation (2007) 0.78
LIVER TRANSPLANTATION IN MAN. Ann N Y Acad Sci (1970) 0.78
The difficulty of eliminating donor leukocyte microchimerism in rat recipients bearing established organ allografts. Transplantation (2006) 0.78
Molecular regulation of hepatic dendritic cell function and its relation to liver transplant outcome. Transplantation (2009) 0.77
''Match and treat'': an effective strategy for transplanting highly sensitized pediatric transplant candidates? Pediatr Transplant (2007) 0.77
HLA matching at the epitope level: the way to go. Clin Transpl (2013) 0.76
Dendritic cell immunobiology in relation to liver transplant outcome. Front Biosci (Elite Ed) (2009) 0.76
Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1? Hum Immunol (2009) 0.76
Kidney/Bone Marrow Transplantation. Dial Transplant (1996) 0.76
Pancreatic complications following orthotopic liver transplantation. Clin Transplant (1992) 0.75
CRITICAL CARE MEDICINE AND LIVER TRANSPLANTATION. Crit Care (1985) 0.75
On the crossroad between tolerance and posttransplant lymphoma. Curr Opin Organ Transplant (1997) 0.75
LONG TERM RESULTS OF HEPATIC TRANSPLANTATION DURING THE CYCLOSPORINE ERA: THE PITTSBURGH EXPERIENCE. Transplant Clin Immunol (1987) 0.75
Cold heparinized lactated Ringers with procaine (HeLP) preservation fluid in 266 living donor kidney transplantations. Transplantation (2007) 0.75
World's longest surviving liver-pancreas recipient. Liver Transpl (2007) 0.75
Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers. Xenotransplantation (1997) 0.75